Aptevo Therapeutics Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
APVO on Nasdaq
Location
2401 4 Th Ave., Suite 1050, Seattle, WA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Aptevo Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marvin L. White President and CEO, Director Jul 17, 2024
Fuad El-Hibri Director Dec 3, 2021
SoYoung Kwon SVP, GC, BD & Corp Affairs Aug 8, 2024
Barbara Lopez Kunz Director Jul 17, 2024
Grady Grant III Director Jul 17, 2024
Jeffrey G. Lamothe Evp, Coo Aug 8, 2024
Kevin Tang Exit Filing Nov 23, 2021
Zsolt Harsanyi Director Jul 17, 2024
Daphne Taylor Svp, Cfo Aug 8, 2024
John Niederhuber Director Jul 17, 2024
Daniel Abdun-Nabi Director Jul 17, 2024

Recent Insider Transactions by Companies or Individuals for Aptevo Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.